Literature DB >> 2840874

Mousepox in inbred mice innately resistant or susceptible to lethal infection with ectromelia virus. IV. Studies with the Moscow strain.

P N Bhatt1, R O Jacoby, L Gras.   

Abstract

The pathogenesis and transmission of infection with the Moscow strain of ectromelia virus were studied in inbred mice. BALB/cAnNcr had high morbidity and mortality and C57BL/6Ncr (B6) mice had high morbidity and low mortality. Virus was detected in B6 mice for 2 weeks after subcutaneous (s.c.) inoculation and infected mice developed lesions compatible with acute mousepox. B6 inoculated by footpad transmitted infection to cagemates for up to five weeks and soiled cages that had housed infected mice were infectious for three weeks. S.c.-inoculated B6 mice also transmitted by contact for 2 weeks. Transmission was attributed to oronasal excretion of virus. Airborne transmission of infection between adjacent cages occurred at a low rate. Ectromelia virus-free progeny were derived from previously infected dams. These studies indicate that the highly virulent and infectious Moscow strain of ectromelia virus caused self-limiting infection in inbred mice and that direct contact is the most efficient means of transmission. These findings support the concept that mousepox can be contained by husbandry practices that minimize or eliminate the spread of infection by direct contact or fomites.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2840874     DOI: 10.1007/BF01487685

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  12 in total

1.  Elimination of mouse hepatitis virus from a breeding colony by temporary cessation of breeding.

Authors:  E C Weir; P N Bhatt; S W Barthold; G A Cameron; P A Simack
Journal:  Lab Anim Sci       Date:  1987-08

2.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

3.  Epizootiology of an outbreak of mousepox at the National Institutes of Health.

Authors:  G D Wallace; R M Werner; P L Golway; D M Hernandez; D W Alling; D A George
Journal:  Lab Anim Sci       Date:  1981-10

4.  Mousepox in inbred mice innately resistant or susceptible to lethal infection with ectromelia virus. I. Clinical responses.

Authors:  P N Bhatt; R O Jacoby
Journal:  Lab Anim Sci       Date:  1987-02

5.  Mousepox in inbred mice innately resistant or susceptible to lethal infection with ectromelia virus. III. Experimental transmission of infection and derivation of virus-free progeny from previously infected dams.

Authors:  P N Bhatt; R O Jacoby
Journal:  Lab Anim Sci       Date:  1987-02

6.  Mousepox in inbred mice innately resistant or susceptible to lethal infection with ectromelia virus. II. Pathogenesis.

Authors:  R O Jacoby; P N Bhatt
Journal:  Lab Anim Sci       Date:  1987-02

7.  Kinetics of ectromelia virus (mousepox) transmission and clinical response in C57BL/6j, BALB/cByj and AKR/J inbred mice.

Authors:  G D Wallace; R M Buller
Journal:  Lab Anim Sci       Date:  1985-02

8.  Studies in mousepox, infectious ectromelia of mice; a comparison of the virulence and infectivity of three strains of ectromelia virus.

Authors:  F FENNER
Journal:  Aust J Exp Biol Med Sci       Date:  1949-01

9.  Mouse-pox; infectious ectromelia of mice; a review.

Authors:  F FENNER
Journal:  J Immunol       Date:  1949-12       Impact factor: 5.422

10.  Pathogenesis of vaccinia (IHD-T) virus infection in BALB/cAnN mice.

Authors:  R O Jacoby; P N Bhatt; E A Johnson; F X Paturzo
Journal:  Lab Anim Sci       Date:  1983-10
View more
  10 in total

1.  Electron microscopy, plaque assay and preliminary serological characterization of three ectromelia virus strains isolated in Poland in the period 1986-1988.

Authors:  I Spohr de Faundez; M Niemialtowski; E Malicka; K Malicki; M Gieryńska; A Popis
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

2.  Evidence that NK cells and interferon are required for genetic resistance to lethal infection with ectromelia virus.

Authors:  R O Jacoby; P N Bhatt; D G Brownstein
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

3.  Mousepox in inbred mice innately resistant or susceptible to lethal infection with ectromelia virus. V. Genetics of resistance to the Moscow strain.

Authors:  D Brownstein; P N Bhatt; R O Jacoby
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

4.  Chromosome mapping of Rmp-4, a gonad-dependent gene encoding host resistance to mousepox.

Authors:  D G Brownstein; L Gras
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

5.  Ectromelia virus replication in major target organs of innately resistant and susceptible mice after intravenous infection.

Authors:  D G Brownstein; P N Bhatt; L Gras
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

Review 6.  Poxvirus pathogenesis.

Authors:  R M Buller; G J Palumbo
Journal:  Microbiol Rev       Date:  1991-03

7.  Serial backcross analysis of genetic resistance to mousepox, using marker loci for Rmp-2 and Rmp-3.

Authors:  D G Brownstein; P N Bhatt; L Gras; T Budris
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

8.  Differential pathogenesis of lethal mousepox in congenic DBA/2 mice implicates natural killer cell receptor NKR-P1 in necrotizing hepatitis and the fifth component of complement in recruitment of circulating leukocytes to spleen.

Authors:  D G Brownstein; L Gras
Journal:  Am J Pathol       Date:  1997-04       Impact factor: 4.307

9.  Antiviral activity of tumor necrosis factor (TNF) is mediated via p55 and p75 TNF receptors.

Authors:  J Ruby; H Bluethmann; J J Peschon
Journal:  J Exp Med       Date:  1997-11-03       Impact factor: 14.307

10.  Comparative Pathogenesis, Genomics and Phylogeography of Mousepox.

Authors:  Carla Mavian; Alberto López-Bueno; Rocío Martín; Andreas Nitsche; Antonio Alcamí
Journal:  Viruses       Date:  2021-06-15       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.